NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Friday:
Turning Point Therapeutics Inc., up $40.43 to $74.59.
Bristol Myers Squibb is buying the biopharmaceutical company for about $4.1 billion.
Calavo Growers Inc., up $4.65 to $37.84.
The avocado grower's fiscal second-quarter earnings and revenue beat analysts' forecasts.
Okta, Inc., up $4.70 to $98.38.
The cloud identity management company raised its earnings forecast for the year.
American Eagle Outfitters Inc., up 81 cents to $12.79.
The clothing retailer announced an accelerated stock buyback program.
Chegg Inc., up 72 cents to $21.14.
The provider of online textbook rental services announced a $1 billion increase in its securities buyback program.
Zumiez Inc., down $3.01 to $31.16.
The clothing retailer gave investors a weak financial forecast.
Tesla Inc., down $71.45 to $703.55.
The electric vehicle maker’s CEO, Elon Musk, has reportedly expressed worries about the economy and the possible need to cut staff.
Kohl's Corp., up 30 cents to $41.48.
The department store operator has reportedly received buyout offers from Sycamore Partners and Franchise Group.
Before you consider Bristol-Myers Squibb, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bristol-Myers Squibb wasn't on the list.
While Bristol-Myers Squibb currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.
Get This Free Report
